Mandruzzato, Susanna

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications

Immune cells in cancerImmunotherapy and Immune Responses

Cited by 2,751

Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion

Zoso, A., Mazza, E. M. C., Bicciato, S., Mandruzzato, S., Bronte, V., Serafini, P., & Inverardi, L. (2014) · European Journal of Immunology

Immune cells in cancerImmunotherapy and Immune Responses

Cited by 123

Reprogramming T Lymphocytes for Melanoma Adoptive Immunotherapy by T-Cell Receptor Gene Transfer with Lentiviral Vectors

Bobisse, S., Rondina, M., Merlo, A., Tisato, V., Mandruzzato, S., Amendola, M., Naldini, L., Willemsen, R. A., Debets, R., Zanovello, P., et al. (2009) · Cancer Research

Virus-based gene therapy researchImmunotherapy and Immune Responses

Cited by 62